Platelet inhibition by low-dose aspirin but not by clopidogrel reduces the axon-reflex current-induced vasodilation in humans

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 294, Issue 5, 2008, Pages

  Rousseau, P ^a   Tartas, M ^a   Fromy, B ^c   Godon, A ^a   Custaud, M A ^a,b   Saumet, J L ^a,c   Abraham, P ^a,b  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ D'ANGERS   (France)

^c UNIVERSITÉ LYON 1   (France)

Author keywords

Axon reflex; Microcirculation; Platelets; Skin

Indexed keywords

ACETYLCHOLINE; ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; CLOPIDOGREL; LYSINE ACETYLSALICYLATE; PLACEBO; ANTITHROMBOCYTIC AGENT; DRUG DERIVATIVE; PROSTAGLANDIN SYNTHASE; TICLOPIDINE; VASODILATOR AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; HYPEREMIA; LASER DOPPLER FLOWMETRY; MALE; MICROCIRCULATION; NORMAL HUMAN; PRIORITY JOURNAL; REFLEX; SKIN BLOOD FLOW; THROMBOCYTE AGGREGATION INHIBITION; VASODILATATION; DRUG EFFECT; ELECTROSTIMULATION; ENZYMOLOGY; IONTOPHORESIS; METABOLISM; NERVE FIBER; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; SIGNAL TRANSDUCTION; THROMBOCYTE; THROMBOCYTE AGGREGATION; VASCULAR ENDOTHELIUM;

ACETYLCHOLINE; ADENOSINE DIPHOSPHATE; ADULT; ASPIRIN; AXONS; BLOOD PLATELETS; ELECTRIC STIMULATION; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; IONTOPHORESIS; LASER-DOPPLER FLOWMETRY; MALE; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SIGNAL TRANSDUCTION; TICLOPIDINE; VASODILATION; VASODILATOR AGENTS;

EID: 45549104515     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00810.2007     Document Type: Article

References (45)

1. Awtry EH, Loscalzo J. Aspirin. Circulation 101: 1206-1218, 2000.
2. Bellien J, Iacob M, Eltchaninoff H, Bourkaib R, Thuillez C, Joannides R. AT1 receptor blockade prevents the decrease in conduit artery flow-mediated dilatation during NOS inhibition in humans. Clin Sci (Lond) 112: 393-401, 2007.
3. Berliner MN. Skin microcirculation during tapwater iontophoresis in humans: cathode stimulates more than anode. Microvasc Res 54: 74-80, 1997.
4. Campbell CL, Berger PB, Nuttall GA, Orford JL, Santrach PJ, Oliver WC, Ereth MH, Thompson CM, Murphy MK, McGlassen DL, Schrader LM, Steinhubl SR. Can N-acetylcysteine reverse the antiplatelet effects of clopidogrel? An in vivo and vitro study. Am Heart J 150: 796-799, 2005.
5. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348: 1329-1339, 1996.
6. Chakrabarti S, Clutton P, Varghese S, Cox D, Mascelli MA, Freedman JE. Glycoprotein IIb/IIIa inhibition enhances platelet nitric oxide release. Thromb Res 113: 225-233, 2004.
7. Cornelissen J, Kirtland S, Lim E, Goddard M, Bellm S, Sheridan K, Large S, Vuylsteke A. Biological efficacy of low against medium dose aspirin regimen after coronary surgery: analysis of platelet function. Thromb Haemost 95: 476-482, 2006.
8. Denninger MH, Necciari J, Serre-Lacroix E, Sissmann J. Clopidogrel antiplatelet activity is independent of age and presence of atherosclerosis. Semin Thromb Hemost 25 Suppl 2: 41-45, 1999.
9. Di Minno G, Cerbone AM, Mattioli PL, Turco S, Iovine C, Mancini M. Functionally thrombasthenic state in normal platelets following the administration of ticlopidine. J Clin Invest 75: 328-338, 1985.
10. Durand S, Fromy B, Bouye P, Saumet JL, Abraham P. Current-induced vasodilation during water iontophoresis (5 min, 0.10 mA) is delayed from current onset and involves aspirin sensitive mechanisms. J Vasc Res 39: 59-71, 2002.
11. Durand S, Fromy B, Bouye P, Saumet JL, Abraham P. Vasodilatation in response to repeated anodal current application in the human skin relies on aspirin-sensitive mechanisms. J Physiol 540: 261-269, 2002.
12. Durand S, Fromy B, Koitka A, Tartas M, Saumet JL, Abraham P. Oral single high-dose aspirin results in a long-lived inhibition of anodal current-induced vasodilatation. Br J Pharmacol 137: 384-390, 2002.
13. Durand S, Fromy B, Tartas M, Jardel A, Saumet JL, Abraham P. Prolonged aspirin inhibition of anodal vasodilation is not due to the trafficking delay of neural mediators. Am J Physiol Regul Integr Comp Physiol 285: R155-R161, 2003.
14. Durand S, Tartas M, Bouye P, Koitka A, Saumet JL, Abraham P. Prostaglandins participate in the late phase of the vascular response to acetylcholine iontophoresis in humans. J Physiol 561: 811-819, 2004.
15. Forstermann U, Mugge A, Bode SM, Frolich JC. Response of human coronary arteries to aggregating platelets: importance of endothelium-derived relaxing factor and prostanoids. Circ Res 63: 306-312, 1988.
16. Hamdy O, Abou-Elenin K, LoGerfo FW, Horton ES, Veves A. Contribution of nerve-axon reflex-related vasodilation to the total skin vasodilation in diabetic patients with and without neuropathy. Diabetes Care 24: 344-349, 2001.
17. Hanley SP, Bevan J, Cockbill SR, Heptinstall S. Differential inhibition by low-dose aspirin of human venous prostacyclin synthesis and platelet thromboxane synthesis. Lancet 1: 969-971, 1981.
18. Heavey DJ, Barrow SE, Hickling NE, Ritter JM. Aspirin causes short-lived inhibition of bradykinin-stimulated prostacyclin production in man. Nature 318: 186-188, 1985.
19. Hla TT, Bailey JM. Differential recovery of prostacyclin synthesis in cultured vascular endothelial vs. smooth muscle cells after inactivation of cyclooxygenase with aspirin. Prostaglandins Leukot Essent Fatty Acids 36: 175-184, 1989.
20. Hoefer IE, Grundmann S, Schirmer S, van Royen N, Meder B, Bode C, Piek JJ, Buschmann IR. Aspirin, but not clopidogrel, reduces collateral conductance in a rabbit model of femoral artery occlusion. J Am Coll Cardiol 46: 994-1001, 2005.
21. Inokuchi K, Hirooka Y, Shimokawa H, Sakai K, Kishi T, Ito K, Kimura Y, Takeshita A. Role of endothelium-derived hyperpolarizing factor in human forearm circulation. Hypertension 42: 919-924, 2003.
22. Jaffe EA, Weksler BB. Recovery of endothelial cell prostacyclin production after inhibition by low doses of aspirin. J Clin Invest 63: 532-535, 1979.
23. Kaul S, Padgett RC, Waack BJ, Brooks RM, Heistad DD. Effect of atherosclerosis on responses of the perfused rabbit carotid artery to human platelets. Arterioscler Thromb 12: 1206-1213, 1992.
24. Labarthe B, Theroux P, Angioi M, Ghitescu M. Matching the evaluation of the clinical efficacy of clopidogrel to platelet function tests relevant to the biological properties of the drug. J Am Coll Cardiol 46: 638-645, 2005.
25. Lefkovits J, Plow EF, Topol EJ. Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. N Engl J Med 332: 1553-1559, 1995.
26. Morris SJ, Shore AC. Skin blood flow responses to the iontophoresis of acetylcholine and sodium nitroprusside in man: possible mechanisms. J Physiol 496: 531-542, 1996.
27. Mortaz E, Redegeld FA, Dunsmore K, Odoms K, Wong HR, Nijkamp FP, Engels F. Stimulation of cysteinyl leukotriene production in mast cells by heat shock and acetylsalicylic acid. Eur J Pharmacol 561: 214-219, 2007.
28. Murugappa S, Kunapuli SP. The role of ADP receptors in platelet function. Front Biosci 11: 1977-1986, 2006.
29. Mustard JF, Kinlough-Rathbone RL, Packham MA. Prostaglandins and platelets. Annu Rev Med 31: 89-96, 1980.
30. O'Kane PD, Queen LR, Ji Y, Reebye V, Stratton P, Jackson G, Ferro A. Aspirin modifies nitric oxide synthase activity in platelets: effects of acute versus chronic aspirin treatment. Cardiovasc Res 59: 152-159, 2003.
31. Oskarsson HJ, Hofmeyer TG. Platelets from patients with diabetes mellitus have impaired ability to mediate vasodilation. J Am Coll Cardiol 27: 1464-1470, 1996.
32. Patrono C, Coller B, Dalen JE, FitzGerald GA, Fuster V, Gent M, Hirsh J, Roth G. Platelet-active drugs: the relationships among dose, effectiveness, and side effects. Chest 119: 39S-63S, 2001.
33. Quinn MJ, Fitzgerald DJ. Ticlopidine and clopidogrel. Circulation 100: 1667-1672, 1999.
34. Ritter JM, Cockcroft JR, Doktor HS, Beacham J, Barrow SE. Differential effect of aspirin on thromboxane and prostaglandin biosynthesis in man. Br J Clin Pharmacol 28: 573-579, 1989.
35. Robbins IM, Kawut SM, Yung D, Reilly MP, Lloyd W, Cunningham G, Loscalzo J, Kimmel SE, Christman BW, Barst RJ. A study of aspirin and clopidogrel in idiopathic pulmonary arterial hypertension. Eur Respir J 27: 578-584, 2006.
36. Roth GJ, Stanford N, Majerus PW. Acetylation of prostaglandin synthase by aspirin. Proc Natl Acad Sci USA 72: 3073-3076, 1975.
37. Savcic M, Hauert J, Bachmann F, Wyld PJ, Geudelin B, Cariou R. Clopidogrel loading dose regimens: kinetic profile of pharmacodynamic response in healthy subjects. Semin Thromb Hemost 25 Suppl 2: 15-19, 1999.
38. Secrest RJ, Chapnick BM. Endothelial-dependent relaxation induced by leukotrienes C4, D4, and E4 in isolated canine arteries. Circ Res 62: 983-991, 1988.
39. Tartas M, Bouye P, Koitka A, Durand S, Gallois Y, Saumet JL, Abraham P. Early vasodilator response to anodal current application in human is not impaired by cyclooxygenase-2 blockade. Am J Physiol Heart Circ Physiol 288: H1668-H1673, 2005.
40. Tartas M, Bouye P, Koitka A, Jaquinandi V, Tan L, Saumet JL, Abraham P. Cathodal current-induced vasodilation to single application and the amplified response to repeated application in humans rely on aspirin-sensitive mechanisms. J Appl Physiol 99: 1538-1544, 2005.
41. Voilley N, de Weille J, Mamet J, Lazdunski M. Nonsteroid anti-inflammatory drugs inhibit both the activity and the inflammation-induced expression of acid-sensing ion channels in nociceptors. J Neurosci 21: 8026-8033, 2001.
42. Vorchheimer DA, Badimon JJ, Fuster V. Platelet glycoprotein IIb/IIIa receptor antagonists in cardiovascular disease. JAMA 281: 1407-1414, 1999.
43. Weksler BB, Pett SB, Alonso D, Richter RC, Stelzer P, Subramanian V, Tack-Goldman K, Gay WA Jr. Differential inhibition by aspirin of vascular and platelet prostaglandin synthesis in atherosclerotic patients. N Engl J Med 308: 800-805, 1983.
44. Westerman RA, Widdop RE, Hannaford J, Hogan C, Roberts R, Zimmet P. Non-invasive tests of neurovascular function. Clin Exp Neurol 24: 129-137, 1987.
45. Yvonne-Tee GB, Rasool AH, Halim AS, Rahman AR. Reproducibility of different laser Doppler fluximetry parameters of postocclusive reactive hyperemia in human forearm skin. J Pharmacol Toxicol Methods 52: 286-292, 2005.